{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:40:07Z","timestamp":1751542807796,"version":"3.41.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04287-1","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:12:57Z","timestamp":1751541177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as aseptic meningitis and multiple cranial neuritis: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Yi-Na","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Jie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"8","key":"4287_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rost\u00e1sy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013;9(8):455\u201361.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"4287_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","volume":"19","author":"T Armangue","year":"2020","unstructured":"Armangue T, Oliv\u00e9-Cirera G, Mart\u00ednez-Hernandez E, et al. Associations of paediatric demyelinating and encephalitic syndromes with Myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol. 2020;19(3):234\u201346.","journal-title":"Lancet Neurol"},{"issue":"9","key":"4287_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S1474-4422(21)00247-7","volume":"20","author":"RC Dale","year":"2021","unstructured":"Dale RC, Ramanathan S. Clinical decision making in MOG antibody-associated disease. Lancet Neurol. 2021;20(9):695\u20137.","journal-title":"Lancet Neurol"},{"issue":"2","key":"4287_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3988\/jcn.2022.0307","volume":"19","author":"S Kim","year":"2023","unstructured":"Kim S, Kim S, Jang Y, Chu K. Leptomeningeal enhancement, a phenotype of Myelin oligodendrocyte glycoprotein Antibody-Associated disease with caudate nucleus involvement: A case report and literature review. J Clin Neurol. 2023;19(2):210\u20133.","journal-title":"J Clin Neurol"},{"key":"4287_CR5","doi-asserted-by":"publisher","first-page":"104939","DOI":"10.1016\/j.msard.2023.104939","volume":"78","author":"M Gu","year":"2023","unstructured":"Gu M, Mo X, Fang Z, et al. Characteristics of aseptic meningitis-like attack-an underestimated phenotype of Myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler Relat Disord. 2023;78:104939.","journal-title":"Mult Scler Relat Disord"},{"key":"4287_CR6","doi-asserted-by":"publisher","first-page":"104126","DOI":"10.1016\/j.msard.2022.104126","volume":"68","author":"S Lin","year":"2022","unstructured":"Lin S, Long W, Wen J, Su Q, Liao J, Hu Z. Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: A novel phenotype. Mult Scler Relat Disord. 2022;68:104126.","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"4287_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/brainsci12111529","volume":"12","author":"Y Du","year":"2022","unstructured":"Du Y, Xiao L, Ding Z, Huang K, Xiao B, Feng L. MOGAD involving cranial neuropathies: A case report and review of literature. Brain Sci. 2022;12(11):1529.","journal-title":"Brain Sci"},{"issue":"12","key":"4287_CR8","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128\u201338.","journal-title":"Brain"},{"issue":"4","key":"4287_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","volume":"75","author":"Y Hacohen","year":"2018","unstructured":"Hacohen Y, Wong YY, Lechner C, et al. Disease course and treatment responses in children with relapsing Myelin oligodendrocyte glycoprotein Antibody-Associated disease. JAMA Neurol. 2018;75(4):478\u201387.","journal-title":"JAMA Neurol"},{"key":"4287_CR10","doi-asserted-by":"publisher","first-page":"102040","DOI":"10.1016\/j.msard.2020.102040","volume":"41","author":"S Kawakami","year":"2020","unstructured":"Kawakami S, Akamine S, Chong PF, et al. Isolated cranial neuritis of the oculomotor nerve: expanding the MOG phenotype. Mult Scler Relat Disord. 2020;41:102040.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"4287_CR11","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1212\/NXI.0000000000000543","volume":"6","author":"A Cobo-Calvo","year":"2019","unstructured":"Cobo-Calvo A, Ayrignac X, Kerschen P, et al. Cranial nerve involvement in patients with MOG antibody-associated disease. Neurol Neuroimmunol Neuroinflamm. 2019;6(2):e543.","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04287-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04287-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04287-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:12:57Z","timestamp":1751541177000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04287-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4287"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04287-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by appropriate regulatory and ethical authorities at the ethics committee of General Hospital of Northern Theatre Command (Y2025-15). We obtained informed consent for treatment purposes and written informed consent for publishing this case report from the patient\u2019 son.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The son of the patient gave written informed consent for all clinical details and images of the patient in this report to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}